D3S-002

N/A

Report date: 2026/05/07 20:00:36

NME

Base Information

Drug NameD3S-002

Drug Alias NameD3S-002

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionExtracellular-signal-regulated kinase1 inhibitorsExtracellular-signal-regulated kinase 2 inhibitors

TargetsExtracellular-signal-regulated kinase1Extracellular-signal-regulated kinase 2

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustraliaSouth Korea +[4]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

China Registration ClassClass 1 Chemical Drug in China

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsNeoplasms

ATC CodeN/A